Tag	Tag2	number_NA	other																																								
lymph_node_involvement_site	lymph_node_involvement_site	5[10.42%] | N/A	8[16.67%] | cervical	6[12.5%] | mesenteric	6[12.5%] | other	2[4.17%] | Axillary	2[4.17%] | Inguinal	2[4.17%] | mediastinal	1[2.08%] | Axillary|cervical|hilar|Iliac-common|Iliac-external|Inguinal|mediastinal|retroperitoneal|supraclavicular	1[2.08%] | Axillary|cervical|hilar|Iliac-common|Iliac-external|mediastinal|mesenteric|para-aortic|retroperitoneal|Splenic	1[2.08%] | Axillary|cervical|Inguinal|mesenteric|supraclavicular	1[2.08%] | Axillary|cervical|Inguinal|retroperitoneal	1[2.08%] | Axillary|cervical|mediastinal|para-aortic	1[2.08%] | Axillary|Inguinal	1[2.08%] | Axillary|para-aortic|Splenic|supraclavicular	1[2.08%] | cervical|Inguinal	1[2.08%] | cervical|mediastinal|para-aortic|supraclavicular	1[2.08%] | cervical|mediastinal|supraclavicular	1[2.08%] | cervical|Submandibular	1[2.08%] | cervical|supraclavicular	1[2.08%] | Femoral|Inguinal	1[2.08%] | hilar|Iliac-common|Inguinal|para-aortic|Splenic	1[2.08%] | para-aortic|retroperitoneal	1[2.08%] | retroperitoneal	1[2.08%] | supraclavicular|Submandibular																		
extranodal_site_involvement	extranodal_sites_involvement_number	11[22.92%] | N/A	13[27.08%] | 0	12[25%] | 1	 6[12.5%] | 2	 4[8.33%] | 3	 1[2.08%] | 4	 1[2.08%] | 6																																			
tumor_resected_max_dimension	maximum_tumor_dimension	10[20.83%] | N/A	6[12.5%] | 3	3[6.25%] | 1.5	2[4.17%] | 10	2[4.17%] | 12	2[4.17%] | 2	2[4.17%] | 2.0	2[4.17%] | 4	1[2.08%] | .42	1[2.08%] | 0.4	1[2.08%] | 1	1[2.08%] | 1.8	1[2.08%] | 15	1[2.08%] | 17	1[2.08%] | 2.1	1[2.08%] | 2.4	1[2.08%] | 2.7	1[2.08%] | 3.4	1[2.08%] | 3.5	1[2.08%] | 4.4	1[2.08%] | 4.5	1[2.08%] | 4.8	1[2.08%] | 5	1[2.08%] | 5.4	1[2.08%] | 5.5	1[2.08%] | 6	1[2.08%] | 7.0															
extranodal_lymphomatous_involvement	extranodal_involvement	2[4.17%] | N/A	25[52.08%] | NO	21[43.75%] | YES																																							
ldh_norm_range_upper	ldh_norm_range_upper	15[31.25%] | N/A	11[22.92%] | 380	10[20.83%] | 450	 7[14.58%] | 618	 2[4.17%] | 192	 1[2.08%] | 185	 1[2.08%] | 250	 1[2.08%] | 260																																		
immunopheotypic_analysis_tested	immunophenotypic_analysis_tested	2[4.17%] | N/A	5[10.42%] | CD20	2[4.17%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20	1[2.08%] | CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD23|CD5|CD30	1[2.08%] | CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD5|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|BCL6 > 30%|CD79a|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig	1[2.08%] | CD10 > 30%|BCL2|CD20|CD138|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD19|P53 >20%|MUM1 > 30%|Cytoplasmic Ig|Surface Ig	1[2.08%] | CD10 > 30%|BCL2|CD20|CD23|CD5	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD22|CD5|CD30|Cytoplasmic Ig|Surface Ig	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD30|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|CD19|CD22|Cytoplasmic Ig|Surface Ig|EBER	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD79a|CD5|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD30|NA	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|CD30|CD15	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig|EBER|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD79a|CD5|CD30|CD15|EBER|ALK|Cytoplasmic Ig	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|PAX5|CD5|CD30|EBER|ALK	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD23|CD5|CD30|EBER|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|BCL6 > 30%|CD30|EBER|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD138|CD15|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|CD20|MUM1 > 30%|Cyclin D1	1[2.08%] | CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|BCL6 > 30%|CD5|Cytoplasmic Ig	1[2.08%] | CD10 > 30%|CD20	1[2.08%] | CD10 > 30%|CD20|BCL6 > 30%	1[2.08%] | CD10 > 30%|CD20|BCL6 > 30%|MUM1 > 30%|CD23|CD79a|PAX5|CD5|CD30|CD15|ALK	1[2.08%] | CD10 > 30%|CD20|CD5|Cyclin D1	1[2.08%] | CD19|CD10 > 30%|BCL2	1[2.08%] | CD19|CD10 > 30%|BCL2|CD20|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD23|PAX5|CD5|CD5	1[2.08%] | CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|BCL6 > 30%|CD23|CD5|EBER	1[2.08%] | CD19|CD10 > 30%|BCL2|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD15|EBER|CD30|Cytoplasmic Ig|Surface Ig	1[2.08%] | CD19|CD10 > 30%|BCL2|P53 >20%|CD20|CD22|BCL6 > 30%|CD23|CD79a|CD5|CD30|Cytoplasmic Ig|Surface Ig	1[2.08%] | CD19|CD10 > 30%|BCL2|P53 >20%|CD20|MUM1 > 30%|CD22|BCL6 > 30%|CD23|CD79a|CD5|Cytoplasmic Ig	1[2.08%] | CD19|CD10 > 30%|CD20|MUM1 > 30%|BCL6 > 30%|CD23|PAX5|CD5|Cyclin D1	1[2.08%] | CD19|CD20|CD22	1[2.08%] | CD20|CD23|PAX5|CD30|CD15|EBER|CD5|Cytoplasmic Ig|Surface Ig	1[2.08%] | CD20|CD30	1[2.08%] | CD20|PAX5
immunopheotypic_analysis_results	immunophenotypic_analysis_results	2[4.17%] | N/A	5[10.42%] | Positive	2[4.17%] | Negative|Positive|Positive|Positive|Positive|Negative	2[4.17%] | Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative	2[4.17%] | Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative	2[4.17%] | Positive|Positive	2[4.17%] | Positive|Positive|Positive	1[2.08%] | Negative|Negative|Positive|Negative|Negative|Negative|Negative	1[2.08%] | Negative|Negative|Positive|Positive|Negative|Positive|Negative|Indeterminate	1[2.08%] | Negative|Positive	1[2.08%] | Negative|Positive|Negative|Negative	1[2.08%] | Negative|Positive|Positive	1[2.08%] | Negative|Positive|Positive|Negative|Negative|Positive|Negative|Negative|Positive|Positive	1[2.08%] | Negative|Positive|Positive|Negative|Negative|Positive|Positive|Negative|Negative|Negative|Negative	1[2.08%] | Negative|Positive|Positive|Positive|Negative|Negative|Negative	1[2.08%] | Negative|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Negative	1[2.08%] | Negative|Positive|Positive|Positive|Negative|Positive|Negative|Positive|Negative|Positive|Negative|Indeterminate	1[2.08%] | Negative|Positive|Positive|Positive|Negative|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative	1[2.08%] | Negative|Positive|Positive|Positive|Positive|Negative|Negative	1[2.08%] | Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate	1[2.08%] | Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative	1[2.08%] | Positive|Negative|Negative|Positive|Positive|Positive|Negative|Negative|Negative	1[2.08%] | Positive|Negative|Positive	1[2.08%] | Positive|Negative|Positive|Negative|Negative	1[2.08%] | Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative	1[2.08%] | Positive|Negative|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Positive	1[2.08%] | Positive|Negative|Positive|Positive|Negative|Negative	1[2.08%] | Positive|Negative|Positive|Positive|Positive|Negative	1[2.08%] | Positive|Negative|Positive|Positive|Positive|Negative|NA	1[2.08%] | Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Negative|Positive|Indeterminate|Indeterminate	1[2.08%] | Positive|Negative|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Positive|Negative|Negative	1[2.08%] | Positive|Positive|Negative|Negative|Positive|Positive|Positive|Positive|Positive|Negative|Negative|Positive|Positive	1[2.08%] | Positive|Positive|Positive|Negative|Negative	1[2.08%] | Positive|Positive|Positive|Negative|Positive|Positive|Negative|Negative|Negative|Negative	1[2.08%] | Positive|Positive|Positive|Negative|Positive|Positive|Positive|Positive|Negative|Positive|Negative|Negative|Indeterminate|Positive	1[2.08%] | Positive|Positive|Positive|Positive|Negative|Negative|Negative|Indeterminate|Indeterminate	1[2.08%] | Positive|Positive|Positive|Positive|Positive|Negative	1[2.08%] | Positive|Positive|Positive|Positive|Positive|Positive				
mib_1_positive_percent_range	mib1_positive_percentage_range	21[43.75%] | N/A	12[25%] | 51 - 75%	11[22.92%] | 76 - 100%	 3[6.25%] | 26 - 50%	 1[2.08%] | 0 - 25%																																					
